THE TAMILNADU CHEMISTS & DRUGGISTS ASSOCIATION (REGD.
)
(Affiliated to All India Organisation of Chemists & Druggists)
D-36, 8th Floor, `D’ Block, Halls Towers, 33, Halls Road, Chennai - 600 008.
E-mail : tncda_sangam@yahoo.co.in Website : www.tncda.com
President:
K. MANOHARAN D.Pharm.,
M/s. Thillai Medicals,
No.29-B, 10th Cross, Main Road,
Thillai Nagar, Trichy - 620 018.
Ph: 0431-2762555. Mobile: 94431 76555
E-mail: manoharan.k2222@gmail.com
Chairman,
Tamilnadu Chemists & Druggists
Welfare Charitable Trust
KR.SENTHIL VADIVEL
Salem, Cell: 98427 26047
Patron
K.R. CHINNAIAH CHETTIAR
Villuppuram, Cell: 9952921010
Organising Secretary
P. ANBALAGAN
Namakkal, Cell: 80980 20244
Chairman, Wholesale Wing
A. BHASKARAN
Trichy, Cell: 94434 77840
Chairman, Co-ordination Comm.
S.A. RAMESH
Chennai, Cell: 98400 50518
Chairman, Retailwing
ANNAM THIRUNAVUKARASU
Kovai, 97886 02345
Chairman - Constitution Com.
K. SHANMUGAM
Tiruvannamalai, Cell: 9361111974
Vice President
A. KARUPPIAH
Kovai, Cell: 94430 37017
Vice President
V.M. KADER MYDEEN
Tirunelveli, Cell: 98420 09964
Vice President
C. MANOHAR
Madurai, Cell: 98424 64021
Vice President
P. THIRULOGACHANDAR
Chennai, Cell: 98408 62882
Joint Secretary
T. ASOKAN
Tirupur, Cell: 98941 00615
Joint Secretary
R. THIRUNAVUKARASU
Dharmapuri / Krishnagiri
94885 64343
TAMILNADU CHEMISTS
Phone : 2819 1522
Hon. General Secretary: Treasurer:
K.K. SELVAN B.Sc., S. ELANGOVAN M.Pharm., M.B.A.
M/s.Sharadha Medicals M/s. LEVISER IMPEX,
8/C, Omalur Main Road, Four Road, Salem - 9. No. 4, West Club Road,
Ph: 0427-235 3353, 403 1318 Shenoy Nagar, Chennai - 600 030.
Mobile : 93609 99909 Mobile: 98843 02901, 95660 51684
E-mail: kkselvan72@gmail.com E-mail: leviserpharma@gmail.com
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Chairman,
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Auditing Committee
CONTENTS
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
P. STEPHEN
Tirunelveli, Cell: 99407 79222
Convenor, Trade Reforms &
1. EDITORIAL Continuous Education
S. SENTHIL KUMAR
2. GENERAL SECRETARY’S DESK Erode, Cell: 98427 39233
Chairman, Arbitration Comm.
3. DISTRICT NEWS A.T. KUMAR
Kanyakumar, Cell: 94431 23370
4. PRODUCT INFORMATION PRO
R. GOVINDARAJ
5. MISCELLANEOUS Perambalur, Cell: 94431 55116
Chairman, Trade Affairs Comm.
12345678901234567890123456789012123456789012345678901234567890121234567 G. SIVAM
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 Thanjavur, Cell: 99422 88588
12345678901234567890123456789012123456789012345678901234567890121234567
TARIFF
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567
12345678901234567890123456789012123456789012345678901234567890121234567 President, Pharmacists Association
FOR ADVERTISEMENTS PER ISSUE Secretary, Pharmacists Association
J.VENKATA SUNDARAM
Size : 18.5 cms x 24.5 cms Cuddalore, Cell: 99944 48464
Chairman, Retail Protection Force
Fourth Cover : Rs. 20,000/- W.S. MOHANKUMAR
Chennai, Cell: 74187 94926
Inside Cover Page : Rs. 15,000/- Chairman,
Retail Welfare Committee
Full Page : Rs. 10,000/- G. VENKATESAN
Kanchi-Chengai, 94434 67035
Chairman,
20% Discount on your yearly contract.
Members Welfare Committee
A. SRINIVASAGAN
“Form-V Price List Publication” Virudhunagar, Cell: 94435 44790
charges Rs. 5,000/- per product / strength. Deputy Secretary
S. ARUL RAJA
(Details of strength, packing, composition GST % etc. to be specified) Sivagangai, Cell: 94430 92258
Deputy Secretary
Total Circulation : 20,000 Copies M. ABDUL JAFFAR
Pudukottai, Cell: 80985 32444
Convenor, Trade & Indusry
Editor : K.K. SELVAN, Mobile: 93609 99909 J. RAMESH BABU
Dindigul, Cell: 98421 23620
3 SEPTEMBER 2019
 jiya§f«
bjhÊÈš bghUS« òfG« r«ghâ¥gJ Äfî« K¡»a«
mijj¡f it¤J¡ bfhŸtJ mij Él K¡»a«
kUe; J tzpfg; ngUkf; f s; midtUf; F k; tzf; f k; kw; W k; kdq; f dpe; j ,dpa
ey;tho;j;Jf;fs;.
caph; fhf;Fk; cd;dj kUe;J njhopypy; <Lgl;Ls;s ehk; Neuk; fhyk; ghuhJ
rl;ljpl;lq;fis kjpj;J kidtp kf;fis kwe;J fhiy Kjy; ,uT tiu kdpj
Neaj;Jld; kUe;J tzpfk; nra;J ngUk; gFjp Neuj;ij kf;fspd; eyDf;fhf ghLgl;L
tUfpNwhk;. gyg;Nghuhl;lq;fSf;fpilNa kUe;J tzpfk; nra;Ak; ehk; ekJ njhopiy
rq;fj;jpd; topfhl;LjYld; njhopiy tpUj;jp nra;J ekf;Fhpa yhgj;ij rhpahfg;
gad;gLj;jpf; nfhz;L jf;f itj;Jf; nfhs;StJ mtrpak;.
kw;wj; njhopy;fspy; nghUl;fspd; tpiy kjpg;G $bdhy;; mg;nghOJ mth;fSf;F
gd;klq;F yhgk; fpilf;Fk;. Mdhy; caph; fhf;Fk; cd;dj kUe;Jfis muR eph;zak;
nra;j Fwpg;gpl;l tpiyf;F Nky; tpw;f KbahJ. gioa tpiyapy; jhd; tpw;f ,aYk;.
kUe;J tpiyfs; mg;gb $bdhYk; $l ,Uf;Fk; kUe;Jfis gioa tpiyf;Fj;jhd;
tpw;f KbAk;. ek; rq;fk; Nghuhb ngw;Wj;je;j yhg rjtPj;ij jaT nra;J midtUk;
Kiwahfg; gad; g Lj; j p rq; f j; j pw; F KO xj; J iog; G je; J eP q ; f Sk; tsh; r ; r p
milAq;fs;.ek;ik ghJfhf;Fk; rq;fj;jpw;Fk; ngUik jhUq;fs;.
js; S gb tpw; g id jil nra; a g; g l; l kUe; J fs; tpw; g idapy; ftdk;
nrYj;Jq;fs;.fhyhtjpahd kUe;Jfis ftdkhf ifahz;L ekf;F ,og;G Vw;glhky;
ghh; j ; J f; nfhs; S q; f s; . cq; f s; %yjdj; i j rhpahd Kiwapy; gad; g Lj; j pf;
nfhs;Sq;fs;.fld;fs; thq;Ftjpy; ftdkhf ,Uq;fs;.
jpUkz Mlk;guk; nrhj;J thq;FtJ Mfpatw;wpy; ftdj;Jld; nray;gLq;fs;.
Mlk; g ur; nryTfis FiwAq; f s; . jpwikAk; Cf; f Kk; kpFe; j Ntiyahl; f is
gad;gLj;jpAk; Gjpa njhopy;El;gj;ij ifahz;Lk; Njitahd msT kUe;Jfis
nfhs;Kjy; ,Ug;G itj;J cq;fs; tzpfj;ij rpwe;j tzpfkhf khw;Wq;fs;. fpilf;Fk;
tha;g;Gfis ey;yKiwapy; gad;gLj;jp fbdkhf cioj;J tpahghuj;jpy; tUkhdj;ij
ngUf;fpf; nfhs;Sq;fs;.
me; j tUkhdk; jhd; cq; f s; tho; f ; i fapd; mbj; j sk; vd; g ij kwe; J
tplhjPh;fs;.tUq;fhyfl;lj;jpy; ve;jj; njhopYk; epr;rakw;w jd;ik tuyhk;.cq;fSf;F
ghJfhg;ghf ,Ug;gJ ek; rq;fk; vd;gij czUq;fs;. KjyPl;il ve;j #o;epiyapYk;
,oe;J tplhjPh;fs;. tuhf;fldpy; ftdk; nrYj;Jq;fs;. Njitia mwpe;J kUe;Jfis
nfhs;Kjy; nra;Aq;fs;. GfOk; ngaUk; gzKk; rk;ghjpg;gJ kpfTk; fbdk;.mij jf;f
itj;Jf; nfhs;tJ mij tpl kpf Kf;fpak; vd;gij czh;eJ ; nray;gl;L ek; tzpfj;jpw;F
ngUik NrUq;fs;.
thœf itaf«! ts®f kUªJ tÂf® ey‹!! X§Ff mt®j« òfœ!!!
v‹W« m‹òl‹
- MáÇa®
TAMILNADU CHEMISTS 4 SEPTEMBER 2019
 General Secretary’s Desk
01.08.2019 Remainder Letter sent to Districts TNCDA affiliation request letter not submitted.
Requested District Units to send at the earliest as the details to be furnished to Registrar
of Societies.
02.08.2019 Letter sent to Thiruvarur of President / Secretary regarding the Disciplinary action
taken against Mr. S. Ramachandran, Former President, TNCDA.
03.08.2019 Letter sent to all District President / Secretary enclosing 2018-19 Annual Report
Copies.
09.08.2019 Letter sent to Mr. Annam A. Thirunavukarsu, Secretary, Kovai District
C & D enclosing AIOCD Ltd share transfer cheque for Sri K. Vijayapandian.
09.08.2019 Letter sent to Mr. P. Ganesan, Villupuram of Member enclosing his original share
certificate of AIOCD Ltd for converting the same into ‘Demat Account’
09.08.2019 Letter sent to Mr. S. Senthilkumar Secretary, Erode District C & D enclosing AIOCD
Ltd share transfer amount cheque for Sri Ponnusamy Kamaraj, Member. Also enclosed
the original share certificate of AIOCD Ltd. of Ms. Srirangan Sakunthala to convert
the same to `Demat Account’.
09.08.2019 Letter sent to Mr. ST. Sockalingam, Secretary, Trichy District C & D enclosing the
Original Share Certificate of AIOCD Ltd. of Sri M. Kumar and Sri M. Vijayakumar,
Members of Trichy C & D. They are asked to convert the shares into Demat Account.
09.08.2019 Letter sent to Mr. K. Shanmugam, President, Trivannamalai C & D enclosing the
AIOCD Ltd. original share certificate of Mr. D. Jayachandran, Mr. K. Sankar, Mr. J.
Sasikumar and Mr. J. Seetharaman to convert the shares into Demat Account.
09.08.2019 Letter sent to Mr. S. Arul Raja, Secretary, Sivagangai District C & D enclosing the
AIOCD Ltd. Original share certificate of Mr. Annamalai Theivigan for converting
the same into Demat Account.
09.08.2019 Letter sent to Mr. C. Nagarathnam, Secretary Ramnad District C & D enclosing the
AIOCD Ltd. original share certificate of Mr. Balusamy Semasekararajan to convert
into Demat Account.
09.08.2019 Letter sent to Mr. M. Singaram, Chennai District Member enclosing the AIOCD Ltd.
Original Share Certificate to convert into Demant Account.
14.08.2019 E-mail sent to All District President / Secretary / Wholesale Wing Chairman / State
Office bearers enclosing the circular sent by AIOCD regarding GST / Leakage /
Breakage / Expiry. Requested them to inform their members accordingly.
19.08.2019 E-mail sent to State Office Bearers regarding Registration of our Land purchase at
Trichy on 28.08.2019. Also informed about office bearers meeting to be held on the
same day.
19.08.2019 Letter sent to Mr. L. Babu, Retail Wing Chairman, Tiruvarur C & D regarding the
discipinatory action taken against him.
31.08.2019 Letter sent to Mr. A.N. Viswam, Secretary, Tanjore regarding TNCDA Treasurer Post.
- General Secretary

TAMILNADU CHEMISTS 5 SEPTEMBER 2019

 bghJ¢brayhs® F¿¥ngL
01.08.2019 “TNCDA Affiliation” É©z¥g foj« mD¥ghj kht£l§fS¡F Ãidñ£lš foj«
mD¥g¥g£lJ. cldoahf mD¥òkhW« nf£L¡bfhŸs¥g£lJ. ïªj jftšfis eh« r§f§fË‹
gâths® mt®fS¡F rk®¥ã¡f nt©L« v‹W« bjÇÉ¡f¥g£lJ.
02.08.2019 âUth%® kht£l jiyt®, brayhs® mt®fS¡F TNCDA K‹dhŸ jiyt® âU. S. uhk¢rªâu‹
mt®fŸ ÛJ vL¡f¥g£LŸs xG§F elto¡if g‰¿ foj« mD¥g¥g£lJ.
03.08.2019 mid¤J kht£l jiyt® brayhs®fS¡F ekJ 2018-19 M©l¿¡if ãuâfŸ mt®fŸ
cW¥ãd®fS¡F bfhL¡FkhW mD¥ã it¡f¥g£lJ.
09.08.2019 âU. m‹d« âUehî¡fuR mt®fŸ, nfhit kht£l kUªJ tÂf®fŸ r§f brayhs® mt®fS¡F
âU. K. É#agh©oa‹ mt®fË‹ AIOCD Ltd. Share Transfer Amount fhnrhiy mD¥g¥g£lJ.
09.08.2019 âU. uhk»UZz‹ ÉG¥òu« kht£l brayhs® mt®fS¡F âU. P. fnzr‹ mt®fË‹ Original
Share Certificate of AIOCD Ltd mD¥g¥g£lJ. mjid Demat Account-š tuî it¡FkhW
m¿îW¤j¥g£lJ.
09.08.2019 âU. S. brªâšFkh® mt®fŸ, <nuhL kht£l kUªJ tÂf®fŸ r§f brayhsU¡F âU. bgh‹DrhÄ
fhkuh{ mt®fË‹ AIOCD Ltd. Share Transfer Amount fhnrhiy mD¥g¥g£lJ. nkY« Ms. $u§f‹
rFªjyh mt®fË‹ Original Share Certificate of AIOCD Ltd. mD¥g¥g£lJ. mjid Demat
Accountš tuî it¡FkhW m¿îW¤j¥g£lJ.
09.08.2019 âU. K. r©Kf« mt®fŸ, âUt©zhkiy kht£l jiyt® mt®fS¡F âU. D. b#arªâu‹
mt®fŸ, âU. K. r§f® mt®fŸ, âU. J. ráFkh® mt®fŸ k‰W« âU. J. ájhuhk‹ M»nahUila
Original Share Certificate of AIOCD Ltd. mD¥g¥g£lJ. mªj cW¥ãd®fis mt®fSila
g§Ffis Demat Accountš tuî it¤J¡bfhŸSkhW m¿îW¤j¥g£lJ.
09.08.2019 âU. S. mUŸuh#h mt®fŸ, átf§fis kht£l brayhs® mt®fS¡F âu. m©zhkiy bjŒåf‹
mt®fË‹ Original Share Certificate of AIOCD Ltd. mD¥g¥g£lJ. nkY« mjid Demat-š
tuî it¤J¡bfhŸSkhW m¿îW¤j¥g£lJ.
09.08.2019 âU. C. ehfbu¤âd« mt®fŸ, ïuhkehjòu kht£l brayhs® mt®fS¡F âU. ghYrhÄ nrknrfuuh#‹
mt®fË‹ Original Share Certificate of AIOCD Ltd. mD¥g¥g£lJ. mjid Demat-š tuî
it¤J¡ bfhŸSkhW m¿îW¤j¥g£lJ.
09.08.2019 âU. M. á§fhu« mt®fŸ, br‹id cW¥ãd® mt®fS¡F mtUila Original Share Certificate
of AIOCD Ltd. mD¥g¥g£lJ. mjid Demat-š tuî it¤J¡ bfhŸSkhW m¿îW¤j¥g£lJ.
14.08.2019 mid¤J kht£l jiyt® / brayhs® / bkh¤j kUªJ tÂf jiyt® k‰W« khÃy îth»fS¡F
Ä‹dŠrš _y« AIOCD mD¥ãa GST/Leakage/Breakage/Expiry g‰¿a R‰w¿¡if mD¥g¥g£lJ.
mªj mªj kht£l cW¥ãd®fS¡F mj‹ Étu§fis vL¤Jiu¡FkhW nf£L¡bfhŸs¥g£lJ.
19.08.2019 khÃy îth»fS¡F Ä‹dŠrš _ykhf ekJ r§f¤â‰F âU¢áÆš th§»íŸs ïl¤â‹
g¤âu¥gâî 28.08.2019 m‹W eilbgW« v‹W« m‹W khÃy îth»fŸ T£l« eilbgW« v‹W«
bjÇÉ¡f¥g£lJ.
19.08.2019 âU. L. ghò, k¡f£ bjhl®ò kUªJ tÂf jiyt®, âUth%® mt®fS¡F mt® ÛJ khÃy r§f«
vL¤JŸs xG§F elto¡if g‰¿ foj« mD¥g¥g£lJ.
30.08.2019 âU. A.N. ÉÞt« mt®fŸ, jŠrhñ® kht£l brayhs® mt®fS¡F khÃy bghUshs® nj®î
bjhl®ghf foj« mD¥g¥g£lJ.
- bghJ¢brayhs®
TAMILNADU CHEMISTS 6 SEPTEMBER 2019
 kht£l brŒâfŸ
ö¤J¡Fo kht£l«

ö¤J¡Fo kht£l kUªJ tÂf®fŸ r§f bra‰FG T£l« 31.08.2019 m‹W kht£l
jiyt® âU. #h‹ ãÇ£nlh mt®fŸ jiyikÆš, kht£l brayhs® âU. S.P. KÅrhÄ mt®fŸ
K‹ÅiyÆš eilbg‰wJ. kht£l bghUshs® âU. S. åug¤âu‹ mt®fŸ khÃy bra‰FG
T£l tuî bryîfis kht£l îth»fS¡F bjÇɤJ x¥òjš bg‰W¡ bfh©lh®fŸ. kht£l
r§f¤â‹ bghJ¡FG el¤JtJ g‰¿ fyªJ Mnyhá¡f¥g£L, Ñœf©l Ô®khd§fŸ xU
kdjhf Ãiwnt‰w¥g£lJ. bra‰FG T£l¤âš Jiz¤jiyt® âU. T. K¤J¡»UZz‹
v‹»w f©z‹ mt®fŸ, âU. nuh»Â bršt« mt®fŸ, Jiz¢brayhs® âU. S.A. MWKf«
mt®fŸ, k¡fŸ bjhl®ò tÂf¥ãÇî jiyt® âU. V. rutz¥bgUkhŸ mt®fŸ, âU. A. uhkrhÄ
mt®fŸ k‰W« áw¥ò miH¥ghs® nfhÉšg£o jhYfh brayhs® âU. S. ghy»UZz‹ M»nah®
fyªJ bfh©ld®.
kht£l r§f âU¢brªö® jhYfh r§f rªjh bjhifia tNš brŒJ cjÉaj‰F ghuh£L«,
khÃy r§f¤â‰F ïl« th§» g¤âu« gâî brŒJ tuyhW gil¤j khÃy îth»fS¡F« ghuh£L
bjÇÉ¡f¥g£lJ. kht£l jiyt® mYtyf¤âš eilbg‰w TB ÉÊ¥òz®î T£l«
eilbg‰wJ bjhl®ghf kht£l cW¥ãd®fS¡F jftš bjÇÉ¡f¥g£lJ. kht£l Rfhjhu
Jiw mâfhÇ mt®fshš el¤j¥g£l o¥âÇah ÉÊ¥òz®î T£l¤âš âushf fyªJ bfh©l
kht£l cW¥ãd®fS¡F e‹¿ bjÇÉ¡f¥g£lJ. kht£l bghJ¡FG T£l« 22.09.2019 m‹W
el¤Jtj‰F x¥òjš bgw¥g£lJ. nfhÉšg£oÆš eilbg‰w khÃy bra‰FG, bghJ¡FG
T£l« áw¥ghf eilbgw x¤JiH¥ò tH§»a kht£l, jhYfh îth»fŸ k‰W« e‹bfhil
tH§»a cW¥ãd®fS¡F e‹¿í« ghuh£L« bjÇÉ¡f¥g£lJ.

TAMILNADU CHEMISTS 7 SEPTEMBER 2019

 br‹id kht£l«

br‹id kht£l kUªJ tÂf®fŸ r§f¤â‹ bra‰FG T£l« 21.08.2019 m‹W SVS
Club-š eilbg‰wJ. jŸSgo ÃWtd§fŸ k‰W« áy M‹iy‹ ÃWtd§fS¡F« kUªJ
jahÇ¥ghs®fŸ áy® neuoahf mâf jŸSgoÆš kUªJ ÉÃnahf« brŒtij f©l¿ªJ mj‰F
ÉL¡f¥g£l nt©LnfhŸ bjhl®ghfî« mâš V‰g£LŸs khWjšfŸ bjhl®ghfî« jiyt®
âU. S.A. unkZ mt®fŸ mit¡F m¿É¤jh®.
njitÆšyhkš k‰w kht£l§fË‹ Étfhu§fËš jiyÆl nt©lh« v‹W« ekJ
kht£l¤â‹ bgaU¡F fs§f« V‰glhkš ïU¡f nt©L« vd brayhs® âU. Fzh âahF
mt®fŸ mit¡F bjÇɤjh®.
mik¥ò brayhs® âU. T. eluh#‹ mt®fŸ kUªjhSe® gântL k‰W« kUªJfË‹
ɉgid, bfhŸKjš rÇgh®¤J it¡f nt©L« ïšiybaÅš áiw j©lid k‰W« mguhj«
vd r£l« ÔÉu¥gL¤j¥g£LŸsJ v‹gij cW¥ãd®fËl« bjÇɤJ ÉÊ¥òz®¢á jUkhW
T¿dh®. fhyhtâahd kUªJfis kh‰¿¡bfhL¡f jÄœehL khÃy T£l¤âš vL¡f¥g£l
Koîfis mid¤J cW¥ãd®fËl« br‹wila brŒa nt©L« vd nf£L¡bfh©lh®.
jÄœehL msÉš jahÇ¥ghs®fËl« ng¢R th®¤ij el¤â tUtij jÄœehL bghUshs®
âU. S. ïs§nfht‹ mt®fŸ bjÇɤjh®. všyh k©ly§fS« bghJ¡FG el¤â rªjh
bjhifia tH§»l nt©L« vd br‹id kht£l bghUshs® âU. J.b#auhk‹ mt®fŸ
T¿dh®. e‹¿ m¿É¥òl‹ T£l« KotilªjJ.
TAMILNADU CHEMISTS 8 SEPTEMBER 2019
 ntÿ® kht£l«

ntÿ® kht£l« fh£gho jhY¡fh kUªJ tÂf®fŸ r§f bghJ¡FG T£l« 28.07.2019
m‹W cW¥ãd®fŸ K‹ÅiyÆš eilbg‰wJ. òâa jiyt®, brayhs® k‰W« bghUshs®
nj®î brŒa¥g£ld®. jiytuhf âU. R. nkhf‹ mt®fS«, brayhsuhf âU. C. euá«k‹
mt®fS«, bghUshsuhf âU. ãuÉ‹Fkh® mt®fS« nj®ªbjL¡f¥g£ld®.
<nuhL kht£l«
<nuhL kht£l kUªJ tÂf®fŸ r§f bra‰FG T£l« 27.08.2019 m‹W <nuhL kht£l
kUªJ tÂf®fŸ r§f f£ol T£l mu§»š kht£l r§f¤jiyt® âU. R.JiurhÄ mt®fË‹
jiyikÆš eilbg‰wJ. <nuhL kht£l kUªJ tÂf®fŸ r§f¤â‹ kht£l îth»fŸ
k‰W« jhY¡fh îth»fŸ T£l« 06.08.2019 m‹W kht£l r§f jiyt® âU. R. JiurhÄ
mt®fË‹ jiyikÆš eilbg‰wJ. T£l¤âš Ôgh k‰W« rhÈk® ÃWtd§fË‹ jiyt®
âU. V. òUnõh¤jk‹ mt®fŸ flªj 7 M©LfËš 148 FHªijfS¡F br‹id m¥nghnyh
kU¤Jtkidíl‹ ïizªJ ïUja mWit Ợir nk‰bfhŸs¥g£lJ. nkY«
jhŒkh®fS¡F 1500¡F nk‰g£l bg©fS¡F Cancer Screening Programme brŒjij ghuh£o
bfsuÉ¡f¥g£lh®.
kht£l r§f¤â‹ ÃYitÆš cŸs rªjh bjhif MfÞ£ 15 njâ¡FŸ tNš brŒJ
Ko¥gJ v‹W« m¤Jl‹ cW¥ãd®fË‹ Biodata Égu§fŸ nrfÇ¡f¥gl nt©L« v‹W«
Koî brŒa¥g£lJ.

TAMILNADU CHEMISTS 9 SEPTEMBER 2019

 jŠrhñ® kht£l«
jŠrhñ® efu kUªJ tÂf®fŸ r§f¡ T£l« 30.08.2019 m‹W jŠrhñÇš eilbg‰wJ.
áw¥ò miH¥ghs®fshf kUªJ f£L¥gh£L¤Jiw cjÉ ïa¡Fd® âU. S.S. KfkJ fkhš
M.Pharm., mt®fS« k‰W« Range I kUªJ f£L¥gh£LJiw mâfhÇ âUkâ. S.L. bjŒthid
M.Pharm., mt®fS« Range II kUªJ f£L¥gh£LJiw mâfhÇ âU. DI. M. m¥Jšfhj®
M.Pharm., fyªJ bfh©lh®fŸ. T£l¤âid efu brayhs® âUkâ. ehf«khŸ uhn#ªâu‹
mt®fŸ bjhl§» it¤jh®fŸ. jiyt® âU. T. r©Kf« mt®fŸ midtiuí« tunt‰W
tunt‰òiu Ãfœ¤âdh®fŸ. mj‹ã‹d® kht£l Mnyhrf® âU. nrhHh. C. knfªâu‹ mt®fŸ
T£l¤âid bjhl®ªJ el¤âdh®fŸ. mt®fŸ ngR«nghJ giHa tuyhWfisí« r§f«
v›thW f£L¡nfh¥ghf eilbg‰W tUtJ g‰¿í« ÉÇthf vL¤J¡T¿dh®fŸ.
mj‹ã‹ mâfhÇfŸ ngR«nghJ VnjD« Short Supply kUªJfŸ ïUªjhš TW«go
nf£L¡bfh©lh®fŸ. nkY« TB Drugs ɉwhš ahU¡F ɉnwh« v‹w jftiyí«
Tw¢brh‹dh®fŸ. nkY« fU¡fiy¥ò¡fhd kUªJfis ahU« th§» ɉf nt©lh« v‹W«
lh¡l®fŸ MnyhridfË‹go kUªJ Ó£L¡F k£Lnk kUªJfis th§»É‰f nt©L«
v‹W nf£L¡bfh©lh®fŸ. nkY« kUªJf£L¥gh£L¤Jiw mâfhÇfŸ, cW¥ãd®fŸ nf£F«
mid¤J nfŸÉfS¡F« gâš mˤjh®fŸ. T£l¤âš kht£l¤jiyt® âU. S. eluh#‹
mt®fS«, kht£l bghUshs® nrhiy âU. G. át« mt®fS« fyªJ bfh©lh®fŸ. Ãiwthf
âU. K. fnzZ mt®fŸ e‹¿íl‹ T£l« Ãiwî bg‰wJ.
9.9.2019 m‹W jŠrhñÇš kUªJ f£L¥gh£L¤Jiw mYtyf¤âš cjÉ ïa¡Fd® âU.
S.S. KfkJ fkhš M.Pharm., mt®fŸ áw¥ò T£l¤â‰F V‰ghL brŒâUªjh®fŸ. mâš
mid¤J mâfhÇfS« fyªJ bfh©lh®fŸ. ïâš jŠrhñ® k©ly¤ij nr®ªj jŠrhñ®,
âUth%®, òJ¡nfh£il, ehf¥g£od¤ij nr®ªj kht£l cW¥ãd®fŸ fyªJ bfh©lh®fŸ.
cjÉ ïa¡Fd® mt®fŸ TW«nghJ kUªJ cÇk« òJ¥ã¡f kUªJ f£L¥gh£L
mYtyf« tunt©L«. tU«nghJ (cÇikahs® mšyJ m§Ñfhu« bg‰w eg®jh‹
tunt©L«). kUªJ cÇk«, efš filÆ‹ KftÇ u¥g® Þlh«¥ bfh©Ltu nt©L«
mj‹ã‹ mâfhÇfshš bfhL¡f¥gL«. ryhÅš jŠrhñ® ghu¤ Þnl£ t§»Æš gz« f£l
nt©L«. ãwF gz« f£oa uÓij bruh¡Þ vL¤J kUªJ f£L¥ghL Jiw mYtyf¤âš
bfhL¤J kW cÇk« njâia m¤jh£áíl‹ bg‰W¡bfhŸsî«.
nkY« cW¥ãd®fŸ TW«nghJ »uhk§fËš cŸst®fŸ tªJ nghtJ áukkhf
ïU¡Fnk v‹W vL¤J¡T¿dh®fŸ. mj‰F ïa¡Fd® mt®fsJ IªJ tUl§fS¡F
xUKiw xUehŸ jhnd bryî brŒ»Ö®fŸ mâš x‹W« áuk« ïU¡fhJ v‹W«. nkY«
ïªj â£l¤ij MWkhj fhy« eilKiw gL¤JtJ v‹W« mâš vJî« áuk§fŸ ïUªjhš
ã‹d® fyªJ Mnyhá¡fyh« v‹W« vL¤J¡T¿dh®fŸ.

TAMILNADU CHEMISTS 10 SEPTEMBER 2019

 nkY« mâfhÇfŸ TW«nghJ filÆš ntiy gh®¤jt®fŸ òâjhf fil it¤jhš
mt®fS¡F ntiy gh®¤jj‰fhd Experience Certificate bfhL¡fyh« v‹W«, mDgt«
ïšyhjt®fŸ ahU« tªJ nf£lhš ntiy gh®¤jj‰fhd Experience Certificateia bfhL¡f
nt©lh« v‹W« nf£L¡bfh©lh®fŸ. nkY« cW¥ãd®fŸ nf£l nfŸÉfŸ mid¤â‰F«
mâfhÇfŸ És¡fkˤjh®fŸ.
Pharmacist kh‰W« nghJ kUªJ f£L¥gh£L mâfhÇfËl« T¿É£L xU
khj¤â‰FŸS« xU filÆ‹ cÇikahs® khW«nghJ òâa cÇikahs® _‹W khj¤â‰FŸ
kh‰¿¡bfhŸs nt©L« v‹W« nkY« cÇk« fhythâahd ã‹ mguhj¤Jl‹ 6 khj¤â‰FŸ
cÇk¤ij fhy Ú£o¥ò brŒJ bfhŸs nt©L« v‹W T¿dh®fŸ.
ÉUJef® kht£l«
ÉUJef® kht£l« ïuh#ghisa« jhYfh btŸË ÉHh T£l« 25.08.2019š m‹W
ïuh#ghisa¤âš eilbg‰wJ. nk‰go T£l¤âš jhYfh r§f¤ jiyt® âU. A. ÓÅthrf‹
mt®fŸ midtiuí« tunt‰W ciu Ãfœ¤âdh®fŸ. jhYfh r§f brayhs® âU. A.
ïuh#u¤âd« mt®fŸ K‹Åiy t»¤jh®fŸ. brayhs® âU. A. ïuh#u¤âd« mt®fŸ r§f¤â‹
25 tUl brašghLfis m¿¡if _y« bjÇɤjh®fŸ. nk‰go T£l¤âš âU. ïuhkrªâu‹
mt®fŸ eLtuhf ïUªJ g£ok‹w« el¤âdh®fŸ. tÂf¤âš K‹ndw bgÇJ« Jiz ÉgJ
“å£L NHyh? btË NHyh?” v‹w jiy¥ãš Äf¢áw¥ghf eif¢Rit g£ok‹w« eilbg‰wJ.
nk‰go T£l¤âš ÉUJef® k©ly ïiz ïa¡Fe® âU. R. ïs§nfht‹ M.Pharm mt®fŸ
r§f brašghLfis thœ¤â ngáí«, cW¥ãd®fŸ fil¥ão¡f nt©oa be¿Kiwfisí«
tÈíW¤âdh®. mL¤J ngáa TNCDA Welfare Trust Chairman âU. K.R. brªâštontš mt®fŸ
r§f¤â‹ brašghLfis thœ¤â ngá, khÃy r§f¤â‹ ts®¢á¡F«, kht£l r§f¤â‹
ts®¢á¡F«, brayh‰¿a gÂÆid Ãidî T®ªjh®. mLJJ ngáa AIOCD bghUshs®,
TNCDA bghJ¢brayhs® âU. K.K. bršt‹ mt®fŸ r§f¤â‹ brašghLfis thœ¤â ngá
cW¥ãd®fË‹ eyD¡hff khÃy r§f« Ó¿a brašâwiknahL brašg£Lbfh©oU¥gij
tÈíW¤â T¿dh®fŸ. mj‹ã‹ò kJiu fhá ÉÞtehj‹ Vb#‹èÞ âU. L. Fkh® mt®fŸ
r§f brašghLfis thœ¤â ngádh®fŸ. âU. P. bgh‹uh{ B.Pharm mt®fŸ r§f¤â‹
brašghLfis thœ¤â ngádh®fŸ. T£l¤âš fyªJ bfh©l 100 cW¥ãd®fS« jhYfh r§f«
tH§»a ntZo, r£il mªJ fyªJ bfh©lJ Äfî« áw¥ghf ïUªjJ. FL«g¤Jl‹
fyªJ bfh©l mid¤J cW¥ãd®fS¡F« áw¥ghd irt mirt czî tH§f¥g£lJ.
kUªJ fil 25 tUl« el¤â ó®¤âahd 40 cW¥ãd®fS¡F e‰rh‹¿jœ tH§»
bfsuÉ¡f¥g£lh®fŸ. fyªJ bfh©l mid¤J cW¥ãd®fS¡F« %. 2000/- kâ¥òŸs
Ãidî gÇR tH§f¥g£lJ. nk‰go T£l¤âš r§f Ô®khdkhf mid¤J cW¥ãd®fS«
jŸSgo ɉgid brŒtâšiy v‹w cWâbkhÊ Ô®khdkhf cW¥ãd®fË‹ x¤JiH¥nghL
Ãiwnt‰w¥g£lJ. ïWâahf jhYfh r§f bghUshs® âU. T. kha¡f©z‹ e‹¿ ciuíl‹
T£l« ïÅnj Koî‰wJ.

TAMILNADU CHEMISTS 11 SEPTEMBER 2019

 ÉG¥òu« kht£l«

ÉG¥òu« kht£l kUªJ tÂf®fŸ r§f bghJ¡FG T£l« 18.08.2019 m‹W kht£l
jiyt® âU. KR. á‹idah br£oah® mt®fŸ jiyikÆš eilbg‰wJ. jiyt® mt®fŸ
tunt‰òiuí«, jiyik ciuí« Ãfœ¤âdh®. kht£l brayhs® âU. N. uhk»UZz‹ mt®fŸ
M©L m¿¡ifí«, kht£l bghUshs® âU. R. kâaHf‹ mt®fŸ 2018-19 M©L¡fhd
Mo£luhš j¡if brŒa¥g£l tuî bryî fz¡»id jh¡fš brŒjh®.
jhYfh thÇahf ÉLg£l cW¥ãd®fis nr®¡F«goí«, kht£l f£ol g elªJ
tUtjhš midtU« x¤JiH¡F«goí«, kiH¡fhy« tUtjhš bl§F, knyÇah ngh‹w
nehŒfis jL¥gj‰fhd ÉÊ¥òz®î ãuRu§fŸ ÉÃnah»¡F«goí« nf£L¡bfhŸs¥g£lJ.
nkY« T£l¤âš k¡fŸ bjhl®ò kUªJ tÂf ãÇî jiyt® âU. A. j©lghÅ mt®fŸ,
mik¥ò brayhs® âU. R. F¿Šátst‹ mt®fŸ, jhYfh jiyt®fŸ, brayhs®fŸ,
bghUshs®fŸ k‰W« cW¥ãd®fŸ mditU« fyªJ bfh©L áw¥ã¤jd®. kht£l
bghUshs® âU. R. kâaHf‹ mt®fŸ e‹¿ Tw T£l« ïÅnj Ãiwî‰wJ.
njÅ kht£l«
njÅ kht£l«, ngho k©ly k¡fŸ bjhl®ò kUªJ tÂf®fŸ r§f T£l« 30.08.2019
m‹W eilbg‰wJ. jiyt® âU. r«g¤ Fkh® mt®fŸ jiyikÆY«, k¡fŸ kUªJ
tÂf®fË‹ m¤jiyt® âU. M.A. fhªâ mt®fË‹ K‹ÅiyÆš T£l« eilbg‰wJ.
tÂf« jŸSgo brŒJ ɉgid brŒgt®fshš Äfî« ghâ¡f¥g£LŸsJ. ï¥bghGJ
M‹iyÅš 30, 40% tiu jŸSgoÆš kUªJfŸ »il¤J¡bfh©oU¡»‹wJ. ïj‰F khÃy
r§f« ešy Ô®î f©L k¡fŸ kUªJ tÂf®fË‹ thœthjhu¤ij fh¥gh‰W«go
nf£L¡bfhŸs¥g£lJ.
ghujãujkÇ‹ k¡fŸ kUªJ filfËš eh« tÂf« brŒí« kUªJfisí« it¤J
tÂf« brŒJ bfh©oU¡»‹wh®fŸ. eh« ɉf Koahj kUªJfS« »il¡»‹wd. ïJ
Étu« gFâ MŒthsÇl« T¿dhš m§F br‹W MŒî brŒa ïayhJ vd TW»‹wh®fŸ.
Mfnt ïj‰F« khÃy r§f« Ô®îfhz nt©L« vd nf£L¡bfhŸs¥g£lJ. cW¥ãd®fË‹
fyªJiuahlY¡F¥ ã‹ bghUshs® âU. T. b#anj› e‹¿ Tw T£l« ïÅnj Ãiwî‰wJ.
TAMILNADU CHEMISTS 12 SEPTEMBER 2019
 jUkòÇ-»UZz»Ç kht£l«

jUkòÇ -»UZz»Ç kht£l kUªJ tÂf®fŸ r§f¤Jl‹ ïizªj C¤j§fiu k©ly

kUªJ tÂf®fŸ r§f« rh®ãš flªj 21.08.2019 mdW khÃy, kht£l r§f îth»fŸ fyªJ
bfh©l K¥bgU« ÉHh Äf¢ áw¥òl‹ bfh©lhl¥g£lJ .
»UZz»Ç kht£l« C¤j§fiu efu« $thÇ âUkz k©lg¤âš C¤j§fiu k©ly
kUªJ tÂf®fŸ r§f¤â‹ rh®ãš C¤j§fiu k©ly kUªJ tÂf®fŸ r§f¤â‹ bghJ¡FG
T£l« k‰W« kUªJ tÂf® FL«g§fŸ g§nf‰F« FL«g ÉHh, òâajhf nj®ªbjL¡fg£l
khÃy îth»fS¡F ghuh£L, kht£l îth»fS¡F ghuh£L vd _‹W ÉHh¡fisí«
cŸsl¡» K¥bgUÉHh áw¥òl‹ bfh©lhl¥g£lJ. ÉHhitbah£o C¤j§fiu efu¤âš
gšntW ïl§fËš t©z gjhiffŸ it¡f¥g£L khÃy, kht£l îth»fS¡F tunt‰ò
mË¡f¥g£lJ
jÄœjhŒ thœ¤â‰F ã‹d® khÃy kht£l îth»fŸ x›bthUtU«
m¿Kf¥gL¤j¥g£ld®. ïªj ÉHhɉ¡F C¤j§fiu k©ly jiyt® C.V.brªjhkiu bršt‹
mt®fŸ jiyik jh§»dh®. ÉHhÉid xU§»iz¤J k©ly xU§»iz¥ghs® âU.
gH.ãuò mt®fŸ tunt‰òiuah‰¿dh®. k©ly bray® âU. S. Phdnrfu‹ mt®fŸ M©l¿¡if
thá¤jh®.
ïªj ÉHhÉš jUkòÇ-»UZz»Ç kht£l kUªJ tÂf®fŸ r§f jiyt® âU.
B.P.KuËju‹ mt®fŸ, bray® âU. V.R.j£ázh_®¤â mt®fŸ, bghUshs® âU. N.K. Mdªj‹
mt®fŸ, òuty® âU. D.G.bt§fnlr‹ mt®fŸ, xU§»iz¥ghs® âU. A.âšäÞt® Fkh®
mt®fŸ, k¡fŸ bjhl®ò kUªJ tÂf® m bghW¥ghs® âU. T.P.ghyhÍ »UZzFkh®
mt®fŸ, khÃy ïiz bray® âU. ïu.âUehî¡fuR mt®fŸ, khÃy k¡fŸ bjhl®ò kUªJ
tÂf® m Jiz jiyt® âU. M.P.m©zhJiu mt®fŸ cŸË£nlh® K‹Åiy t»¤J
ciuah‰¿d®

TAMILNADU CHEMISTS 13 SEPTEMBER 2019

 òâajhf bghW¥ng‰WŸs khÃy kht£l îth»fis jUkòÇ -»UZz»Ç kht£l bkh¤j
kUªJ tÂf® m jiyt® âU. C.fªjrhÄ mt®fŸ ghuh£o ciuah‰¿aJl‹ khÃy msÉš
10 M« tF¥ãš KjÈl« ão¤j fšyhÉ bt§fnlÞtuh bko¡fšÞ âU. v.njtuh#‹
mt®fË‹ òjšÉ bršÉ. D.átuŠrÅ mt®fis ghuh£o gÇR k‰W« rh‹¿jœ tH§»
áw¥ã¤jh®. ÉHhÉš áw¥ò ÉUªâduhf fyªJ bfh©l fšÉahs® âU. nt.rªâunrfu‹
mt®fŸ khzÉ¡F« mtuJ bg‰nwh®fS¡F« bgh‹dhil mÂɤJ ghuh£odh®.
TAC Committee Chairman âU. nrhiy. G. át« mt®fŸ, khÃy Jiz bray®
âU. T. mnrhf‹ mt®fŸ, k¡fŸ bjhl®ò ey m jiyt® âU. G. bt§fnlr‹ mt®fŸ, âU¢á
kht£l jiyt® âU. P. »Ughdªj _®¤â mt®fŸ, cŸË£l gy® K¥bgU«ÉHhÉš áw¥ò
miH¥ghsuhf fyªJ bfh©L thœ¤Jiuah‰¿d®. tUif jªâUªj khÃy, kht£l, áw¥ò
miH¥ghs®fŸ midtU¡F« bgh‹dhil mÂɤJ Ãidî gÇR tH§» áw¥ã¡f¥g£lJ
jÄœehL kUªJ tÂf®fŸ r§f jiyt® âU. K. kndhfu‹ mt®fS«, brayhs® âU.
K.K. bršt‹ mt®fS«, bghUshs® âU. S. ïs§nfht‹ mt®fS« ghuh£oid bg‰W
V‰òiuíl‹ Toa áw¥òiu tH§»d®. kUªJ tÂf« ï‹iw¡F vâ®bfh©LŸs rthšfŸ
F¿¤J« khÃy r§f« M‰¿ tU« gÂfŸ F¿¤J« T£l¤âš ÉtÇ¡f¥g£lJ . Ãiwthf
jUkòÇ-»UZz»Ç kht£l kUªJ tÂf® r§f bra‰FG cW¥ãd® âU. A. át¡Fkh®
e‹¿íiu eÉy eh£L¥g©Dl‹ ÉHh Ãiwî bg‰wJ.
K¥bgU« ÉHhɉF tUif jªâUªj midtU¡F« áw¥ghd kâa ÉUªJl‹ Ãidî
gÇR tH§f¥g£lJ. Äf ÉÇthd V‰ghLl‹ Äfî« ne®¤âahf totik¡fg£l ÉHh V‰ghLfŸ
F¿¤J gyU« ghuh£L bjÇɤjd®. K¥bgU« ÉHh áw¥òl‹ el¤âa k©ly
bghW¥ghs®fS¡F khÃy, kht£l r§f bghW¥ghs®fŸ bgh‹dhil mÂɤJ ghuh£L
bjÇɤjd®.
âUt©zhkiy kht£l«
âUt©zhkiy kht£l kUªJ tÂf®fŸ bra‰FG T£l« 11.8.2019 m‹W
âUt©zhkiy kht£l kUªJ tÂf®fŸ r§f f£ol¤âš ïiwtz¡f¤Jl‹ bjhl§»
eilbg‰wJ. kht£l kUªJ tÂf®fŸ r§f jiyt® âU. K. r©Kf« mt®fŸ, bghUshs®
âU. D. rhªâ uh#& mt®fŸ, kht£l Mnyhrf® âU. S. KuË mt®fŸ, kht£l òuty® âU. KR.
m©zhkiy mt®fŸ, kht£l cjɤ jiyt® âU. V. òUnõh¤jk‹ mt®fŸ, âU. P. uh#&
mt®fŸ, kht£l bkh¤j kUªJ tÂf®fŸ ãÇî jiyt® âU. J. ïuhjh»UZz‹ mt®fŸ,

TAMILNADU CHEMISTS 14 SEPTEMBER 2019

kht£l k¡fŸ bjhl®ò kUªJ tÂf®fŸ ãÇî jiyt® âU. N. RnuZ mt®fŸ, kht£l mik¥ò
brayhs® âU. S. nrf® mt®fŸ, kht£l ïiz¢ brayhs® âU. G. mŒa¥g‹ mt®fŸ, kht£l
bkh¤j tÂf ãÇî Co-Chairman âU. K. ãnu«Fkh® mt®fŸ, âU. K. FkhurhÄ mt®fŸ
k‰W« k¡fŸ bjhl®ò tÂf Co-Chairman âU. T. fhkuhr‹ mt®fŸ, âU. K. nr£L M»na®
K‹ÅiyÆš áw¥ghf eilbg‰wJ.
jiyt® jdJ jiyikíiuÆš khÃy r§f¤â‹ K¡»a KoîfŸ k‰W« ekJ tÂf«
rh®ªj j‰nghija Étu§fis bjÇa¥gL¤âdh®. nkY« khÃy r§f« âU¢áÆš f£ol« f£l
ïl« th§»íŸsJ g‰¿ bjÇɤjh®. kht£l bra‰FG cW¥ãd®fŸ khÃy r§f Ka‰á¡F
Äf¥bgÇa bt‰¿¡F j§fË‹ thœ¤Jfis bjÇɤjh®fŸ. ïªj M©L bghJ¡FG, nj®jš
bghJ¡FGthf eilbgWtjhš bra‰FGÉš 2019-22 M©o‰fhd kht£l Office BearerfŸ
nj®î brŒa nt©Lbkd T¿dh®. bra‰FGÉ‹ òâa îth»fŸ g‰¿ ÉÇthf Éthâ¡f¥g£L
2019-22 M©o‰fhd îth»fŸ gǪJiu bra‰FG Ô®khŤJ Koî brŒa nt©Lbk‹W
T¿aij V‰W xU áy gjÉia jÉu k‰w K¡»a bghW¥òfS¡F Vfkdjhf nj®î brŒJ
bra‰FG gǪJiu brŒJŸsJ. nkY« khÃy îth»fŸ jiyt®, bghJ¢brayhs®, bghUshs®,
mik¥ò brayhs® M»nahiu miH¡f Ô®khÅ¡f¥g£lJ. m¤Jl‹ nj®jšh gh®itahsuhf
khÃy r§f« khÃy îth»fis mD¥òkhW foj« mD¥g bghJ¡FGÉš Ô®khÅ¡f¥g£lJ
brayhs® jdJ ciuÆš nghd bghJ¡FGÉš ïªj bghJ¡FG tiuÆš eilbg‰w
K¡»a Ãfœîfis vL¤J¡T¿, ekJ cW¥ãd®fŸ r£l k‰W« ÉâfË‹ go tÂf« brŒa
nf£L¡ bfh©ld®.
bghUshs® 1.4.2018 Kjš 31.3.2019 tiu tuî - bryî fz¡Ffis bra‰FGÉš rk®ã¤J
x¥òjš bg‰wh®. nkY« tUif jU« midtU¡F« e‹¿ bjÇɤjh®. T£l« njáa Ñj¤Jl‹
Ãiwî bg‰wJ.

ghuh£L ÉHh
ÉG¥òu« kht£l«, r§fuhòu« muR bko¡fšÞ cÇikahs® Rtn. RM.
K¤JfU¥g‹ mt®fS¡F r®tnjr nuh£lÇ r§f¤âš cyf msÉš
16 ÉUªjhËfËš xUtuhf ïªâa msÉš nj®î brŒa¥g£L nghÈnah ãsÞ
gaÂa® mth®L bg‰WŸsh®fŸ. mt®fS¡F khÃy, kht£l r§f¤â‹ rh®ghf
thœ¤J¡fis bjÇɤJ¡ bfhŸ»nwh«. 29.08.2019 m‹W r§fuhòu¤âš mt®fS¡F
ghuh£L ÉHh eilbg‰wJ. kUªJ tÂf®fŸ fyªJ bfh©L áw¥ã¤jd®.

TAMILNADU CHEMISTS 15 SEPTEMBER 2019

 thœ¤J»nwh«

ntÿ® kht£l kUªJ tÂf®fŸ r§f bra‰FG cW¥ãdU«, TNCDA îth»íkh»a

âU. S. ghyhÍ mt®fŸ òjšÉ bršÉ B. r«í¡jh M.S., bršt‹ V.U. $Åt¤[‹ v‹»w
ghyR¥ãukÂa‹ M.S., M»nahuJ âUkz« 25.08.2019 m‹W br‹idÆš âUkz«
eilbg‰wJ. ï¤âUkz¤âš jiyt® âU. K. kndhfu‹ mt®fŸ, bghJ¢brayhs®
âU. K.K. bršt‹ mt®fŸ, bghUshs® âU. S. ïs§nfht‹ mt®fŸ k‰W« mid¤J khÃy /
kht£l îth»fŸ fyªJ bfh©L áw¥ã¤jd®.

ntÿ® kht£l jiyt® âU. M. Jiu¡f©z‹ mt®fË‹ $ f#y£RÄ ~gh®khN£ofšÞ

bkh¤j kUªJ tÂf ɉgid Tl¤ij 11.09.2019 m‹W khÃy bghJ¢brayhs®
âU. K.K. bršt‹ mt®fŸ âwªJ it¤jh®fŸ. kht£l brayhs® âU. D. nejhÍ mt®fŸ,
bghUshs® âU. P. nfhã mt®fŸ k‰W« kht£l îth»fŸ fyªJ bfh©L áw¥ã¤jd®.
TAMILNADU CHEMISTS 16 SEPTEMBER 2019
 thœ¤J»nwh«

òJ¡nfh£il kht£l jiyt® âU. M. brªâš gHÅa¥g‹ mt®fË‹ kf‹ âUkz ÉHh
08.09.2019 m‹W òJ¡nfh£ilÆš áw¥ghf eilbg‰wJ. khÃy jiyt® âU. K. kndhfu‹
mt®fŸ, bghJ¢brayhs® âU. K.K. bršt‹ mt®fŸ k‰W« khÃy, kht£l îth»fŸ fyªJ
bfh©L áw¥ã¤jd®.

flÿ® kht£l K‹dhŸ brayhsU«, r§f¤â‹ _¤j îth»íkhd âU. G. FU_®¤â

mt®fŸ - âUkâ. G. átfhkRªjÇ ït®fË‹ õZoa¥jó®¤â rhªâ RgKA&®¤j ÉHh flÿ®
kht£l« beŒntÈÆš 31.08.2019 m‹W btF ÉkÇirahf eilbg‰wJ. Trust Chairman âU.
K.R. brªâš tontš mt®fŸ, Patron âU. K.R. á‹idah br£oah® mt®fŸ, jiyt® âU. K.
kndhfu‹ mt®fŸ, bghJ¢brayhs® âU. K.K. bršt‹ mt®fŸ k‰W« khÃy kht£l îth»fŸ
fyªJ bfh©L áw¥ã¤jd®.
TAMILNADU CHEMISTS 17 SEPTEMBER 2019
 thœ¤J»nwh«

jÄœehL kUªJ tÂf®fŸ r§f¤â‹ Jiz¤jiytU«, âUbešntÈ kht£l¤â‹

brayhsUkhd âU. V.M. fhj®ikÔ‹ mt®fË‹ rnfhju® âU. V.M. m¥Jš fhj® mt®fË‹
kfŸ âUkz« 01.09.2019 m‹W filaešÿÇš btF áw¥ghf eilbg‰wJ. kzkfŸ
Dr. i#dgh, B.S.M.S., - kzkf‹ Er. KfkJ cigRš f®Â B.Tech. ït®fSila
âUkz¤âš TNCDA Trust Chairman âU. K.R. brªâštontš mt®fŸ khÃy jiyt®
âU. K. kndhfu‹ mt®fŸ, bghJ¢brayhs® âU. K.K. bršt‹ mt®fŸ k‰W« khÃy
kht£l îth»fŸ fyªJ bfh©ld®.
****
br‹id kht£l kUªJ tÂf®fŸ r§f¤â‹ jiytU«, jÄœehL kUªJ tÂf®fŸ
r§f¤â‹ Co-Ordn. Chairman kh»a âU. S.A. unkZ mt®fË‹ òjšÉ bršÉ R.
r©Kf¥ãÇa bršt‹ âU. M. AÇAuRj‹ ït®fË‹ âUkz« 11.09.2019 m‹W âU¢áÆš
eilbg‰wJ. ï¤âUkz ÉHhÉš khÃy jiyt® âU. K. kndhfu‹ mt®fŸ,
bghJ¢brayhs® âU. K.K. bršt ‹mt®fŸ, bghUshs® âU. S. ïs§nfht‹ mt®fŸ k‰W«
khÃy, kht£l îth»fŸ fyªJ bfh©L áw¥ã¤jd®.
â©L¡fš kht£l« bfhil¡fhzš jhY¡fh K.C. g£oÆš cŸs J®fh bko¡fšÞ
cÇikahs® âU. á¤uh kÂf©l‹ mt®fË‹ òjšÉ bršÉ M. É#ayºÄ B.E.
mt®fË‹ âUkz«1.9.2019 m‹W âUtŸq® kht£l« nty¥g‹ rhtoÆš cŸs mur‹
kAhÈš ïÅnj eilbg‰wJ.

TAMILNADU CHEMISTS 18 SEPTEMBER 2019

 thœ¤J»nwh«
ehk¡fš kht£l«, ehk¡fš jhY¡fh _¤j cW¥ãd® nkhf}® Ó¤jh bko¡fšÞ
cÇikahs® âU. S.M. b#arªâunghÞ - mkuhtâ mt®fË‹ Fkhu¤â bršÉ J. b#aãÇjh
b.Tech, - bršt‹ A. kâaHf‹ B.E. M»nahuJ âUkz tunt‰ò ÉHh 7.9.2019 m‹W áw¥ghf
eilbg‰wJ.
<nuhL kht£l kUªJ tÂf r§f¤â‹ K‹dhŸ brayhŸh âU. N. #h»® cnr‹
mt®fsJ kfŸ jÞÈkh eÞÇ‹ KA«kJ k‰W« Ã#h«Ô‹ M»nah®fË‹ âUkz«
21.07.2019 m‹W áw¥ghf eilbg‰wJ.
ntÿ® kht£l r§f cW¥ãd® M«ò® G. r©Kf« bko¡fšÞ cÇikahs® âU. V.S.
ckhgâ mt®fË‹ òjšÉ bršÉ r«í¡jh M.S. U.S.A. k‰W« bršt‹ $t¤[‹ M.S.U.S.A.
M»nahuJ âUkz« 25.08.2019 m‹W eilbg‰wJ.
òJ¡nfh£il kht£l«, òJ¡nfh£il lî‹, $ Ûdh£á gh®khN£ofšÞ cÇikahs®
âU. bgh‹. gh. uh#‹ - R. ckhuh#‹ ït®fsJ kfŸ bršÉ R. nuhΠ- V.K. âthf®
M»nahuJ âUkz« 11.7.19 m‹W eilbg‰wJ.
òJ¡nfh£il kht£l«, òJ¡nfh£il lî‹, myK bko¡fš V#‹ÓÞ cÇikahs®
âU. V. uhn#ªâu‹ - R. fyhtâ òjšt‹ bršt‹ R. ehfuh#‹ - AL. mHF fhzh«ãfh
ït®fsJ âUkz« 02.09.2019 m‹W eilbg‰wJ.
âUtŸq® kht£l r§f cW¥ãdU«, bghj£^®ng£il $ m«ãfh bko¡fšÞ
cÇikahsUkhd âU. E.C. âUPhd r«gªj« mt®fË‹ Fkhu® bršt‹ âU. E.T.
nyhnfZFkh® B.E., B.Ed., mt®fS¡F« bršÉ A.B. Ãntjh B.E. mt®fS¡F« 02.09.2019
m‹W âUkz« eilbg‰wJ.
nrh˧f® euá«kh bko¡fšÞ cÇikahs® âU. M. nõ¡ fhj® ghõh B.Sc., D.Pharm.,
mt®fË‹ ïisa kfŸ bršÉ K. m®Îah j‹å® M.C.A., B.E.D., - bršt‹ gRš mÛ®
ghõh M.Tech., M.B.A. M»nahuJ âUkz« 23.06.2019 m‹W PhƉW¡»Hik m‹W
eilbg‰wJ.
òJ¡nfh£il kht£l«, fhu«g¡Fo $ »UZzh bko¡fšÞ cÇikahs® âU. R.
ã¢irah ït®fË‹ FHªijfŸ P. á¥jh njÉ - P. rhÈÅ fhj ÉHh 14.8.2019 m‹W
eilbg‰wJ.
òJ¡nfh£il kht£l«, òJ¡nfh£il lî‹, ü® bko¡fš Vb#‹ÓÞ âU.
brh¡fȧf« mt®fsJ òJkid òFÉHh òJ¡nfh£ilÆš 25.08.2019 m‹W eilbg‰wJ.
òJ¡nfh£il kht£l«, òJ¡nfh£il lî‹, ü® bko¡fš V#‹ÓÞ âU. nrhiya¥g‹
mt®fsJ òJkid òFÉHh 01.09.2019 m‹W òJ¡nfh£ilÆš eilbg‰wJ.
ïÅa e‹dhËš ïšthœ¡if bjhl§F« ï¤j«gâa®fS¡F«, ÉHh fhQ«
cW¥ãd®fS¡F« khÃy r§f¤â‹ ešyhá k‰W« kd§fŪj ešthœ¤J¡fŸ.

TAMILNADU CHEMISTS 19 SEPTEMBER 2019

 NEW PRODUCTS PRICE LIST (Form V)
P.T.S. P.T.R.
Product Pack Rate Margin Rate Margin M.R.P.
% %
ABBOTT HEALTHCARE PVT. LTD.
TIXYLIX P SYRUP 60 ml 57.21 10 63.57 20 89.00
pholcodine 1.5 mg,promethazine 1.5 mg

AJANTA PHARMA LIMITED

BIOSILK CREAM 100 gm 212.34 10 235.93 20 348.00
colloidal oatmeal --,ceramide complex —

CLENIA FACE WASH GEL 100 ml 212.95 10 236.61 20 349.00

niacinamide 2.0%,pyridoxine —,4-cyclic phosphate 0.75% w/w,aloe
vera liquid extract 1.5% w/w

APEX LABORATORIES PVT. LTD.

LM FOLINZ TABLETS 10s 77.14 10 85.71 20 120.00
calcium l-5 methyltetrahydrofolate 1 mg,methylcobalamin i.p. 1500
mcg,pyridoxal-5 phosphate 0.5 mg

CACHET PHARMACEUTICALS PVT LTD.,

SPID COLD SYRUP 60 ml 35.36 10 39.29 20 55.00
phenylephrine hydrochloride ip 5 mg,chlorpheniramine
maleate ip 2 mg

SPID COLD TABLET 10s 27.32 10 30.36 20 42.50

paracetamol i.p 500 mg,phenylephrine hydrochloride i.p 10
mg,chlorpheniramine maleate ip 4 mg

SPID KID 60 ml 43.71 10 48.57 20 68.00

levosalbutamol sulphate ip 0.5 mg,ambroxol hydrochloride ip 15
mg,guaiphenesin ip 50 mg

CADILA PHARMACEUTICALS.
HAEM UP RICE CAP 10s 90.91 10 101.02 20 149.00
elemental iron 30 mg,folic acid 250 mcg,energy 1.848 kcal,protein
0.025 g,carbohydrate 0.41 g,fat 0.012 g

H & H PHARMACEUTICA PVT. LTD.

DKGEL-XL GEL 50 gm 127.93 10 142.12 20 199.00
miconazole i.p 2% w/w

HHMITE-XL CREAM 60 gm 73.35 10 81.50 20 114.10

miconazole nitrate 2% w/w

KZ-XL CREAM 50 gm 179.36 10 199.29 20 279.00

permethrin 50 mg

LZHH-XL CREAM 50 gm 256.50 10 285.00 20 399.00

ketoconazole 2.00% w/w

MUPI-XL OINTMENT 15 gm 134.36 10 149.29 20 209.00

luliconazole 1.0% w/w

TRFY-XL CREAM 50 gm 179.36 10 199.29 20 279.00

mupirocin ip 2.0% w/w/

TAMILNADU CHEMISTS 20 SEPTEMBER 2019

 P.T.S. P.T.R.
Product Pack Rate Margin Rate Margin M.R.P.
% %
INDCHEMIE HEALTH SPECIALITIES PVT. LTD.
KEFMAX - O 10s 136.29 10 151.43 20 212.00
cefpodoxime proxetil 200 mg,ofloxacin 200 mg

J.B. CHEMICALS & PHARMACEUTICALS LTD.,

MYOTAN CT 6.25 10s 75.21 10 83.57 20 117.00
azilsartan medoxamil 40 mg,chlorthalidone 6.25 mg

KOYE PHARMACEUTICALS
COELONE 40 MG INJ vial 38.03 10 42.25 20 59.15
methylpredinosolone sodium succinate usp 40 mg

COE-ORS-PRO 1s 27.46 10 30.51 20 45.00

sodium chloride 660 mg,potassium chloride 385 mg,sodium citrate
735 mg,anhydrous glucose 3385 mg,ascorbic acid 40 mg,
zinc gluconate 10 mg,saccharomyces boulardil 250 mg,
bacillus clausil 20 mg,lactobacillus rhamnosus 15 mg

LUPIN LIMITED.,
CORCIUM HD TABS 10x10s 1,403.39 10 1,559.32 20 2,300.00
calcium carbonate ip equivalent to elemental calcium 500 mg,cissus
quadrangularis dry extract 500 mg,cholecalciferol(vitamin d3) 400
iu,vitamin k2 25 mcg

GLUCONFORM 10x15T 718.07 10 797.86 20 1,117.00

gliclazide ip 80 mg,metformin hydrochloride ip 500 mg

T VOBIT VX 1 TAB 10x10s 646.71 10 718.57 20 1,006.00

voglibose i.p. 0.3 mg,glimepride i.p. 1 mg,metformin hydrocloride ip
500 mg

T VOBIT VX 2 TAB 10x10s 793.93 10 882.14 20 1,235.00

voglibose i.p. 0.3 mg,glimipride ip 2 mg,metformin hydrochloride i.p.
500 mg

WOCKHARDT LIMITED.,
CANDIGURD 100 MG 4s 46.29 10 51.43 20 72.00
itraconazole bp 100 mg

VAL 450 2T 2s 630.85 10 700.95 20 920.00

valganciclovir hydrochloride 450 mg

Note : M.R.P. I - Inclusive of All Taxes

Margin - On Selling Price without Tax

For actual product combination, please refer original pack or label.

Visit our Website “www.tncda.com”

for updated information
TAMILNADU CHEMISTS 21 SEPTEMBER 2019
 Best Wishes for
World Pharmacist Day 25th September 2019
TAMILNADU MARUNTHALUNAR SANGAM
(Reg. No. 147/2016)
D-36, 8th Floor, 33 Halls Road, Egmore, Chennai - 600 008.
Gen. Secretary Treasurer
J. VENKATA SUNDARAM G. ASHOK
J.V.S. Pharma House, Preethi Medicals,
4/18, ANH Complex, 1, Indira Gandhi Road,
West Car Street, Chidambaram, Oil Mill Stop, Tiruvallur 1
(M) 99944 48484 (M) 94431 91393
E-mail: sundarvenkat31@gmail.com E-Mail: ashok.g641@gmail.com

The theme of this year’s World Pharmacists Day, is “Safe and effective medicines for all,” according
to the International Pharmaceutical Federation
“Pharmacists are the last line of defense for safe dispensing of medications, and often the first line
of opportunity to make the most of them,”
World Pharmacist Day, seeks to raise awareness in the health care space and among the general
public to provide a better understanding of who pharmacists are and just how important they are for
overall patient health.
The goal of the Pharmacist campaign is to break certain assumptions and show another side of
pharmacists.
Pharmacists make a difference every day in the pharmacy and in their personal lives.
This is an excellent opportunity to show the world how pharmacists can help everyone to use
medicines to their best potential!
Happy World Pharmacist Day! We don’t always make the medications, but we make them better.

TAMILNADU CHEMISTS 22 SEPTEMBER 2019

ESTD.] [1975

AIOCD
ALL INDIA ORGANISATION OF CHEMISTS & DRUGGISTS ®
201, Safalya Bldg., 2nd Floor, Opp. Jaigopal Industrial Estate, Baburao Parulekar Marg, Dadar (W), Mumbai 400 028.
Tel.: 2430 6889 / 2430 6874 / 6145 2929 l Fax: 2430 6973 / 6145 2925 l Visit us on : www.aiocd.net
President : Hon. Gen. Secretary :
J.S. SHINDE RAJIV SINGHAL
Email: aiocd@vsnl.net M/s. Shree Radhey Trade Logistics,
jagannath.shinde@aiocd.com Prabhu Kripa 120, S.R. Compound,
Lasudia, Indore - 452 010, M.P.
Tel. : 0731 - 4002350 Mob.: 9425056394
E-mail: gsrajiv.singhal@aiocd.com

SUGGESTIONS / COMMENTS / OBJECTION ON DRAFT OF E-PHARMACY

Date: 22nd July 2019
Ref: MHFW/AIOCD/411/2019
To,
Hon’ble Shri. Mansukh Mandaviyaji
Minister of State - Shipping, Chemicals & Fertilizers, Govt. of India
Room No. 201, Transport Bhavan
New Delhi - 110 001
Sub : SUGGESTIONS / COMMENTS / OBJECTION ON DRAFT OF
E-PHARMACY
Ref : Draft G.S.R. 817(E) dated 28th August, 2018 published by
Ministry of Health and Family welfare,
Department of Health and Family Welfare Govt. of India, New Delhi.
Sir/Madam,
All India Organisation of Chemists and Druggists (AIOCD) is an apex body of about 8 lacs
Chemists and Druggists spread throughout the country. The main activity comprises of
protecting our members interests, educate them through seminars and workshop, to act as
an interface between industry, government and trade. We represent the grievances of our
members before the government, industrial bodies and seek the redressal of their grievances.
We also support and supplement the government’s role in healthcare sector by ensuring
availability of medicines in the nook & corner of the country.
This is with reference to proposed regulation, we are submitting following suggestions,
objections, and communicating certain alarming hazard to society due to proposed e-
pharmacy.
Regd. Office : AIOCD, C/o. B.C.D.A., 10, Bonfield Lane, 1st Floor, Kolkata - 700 001.

TAMILNADU CHEMISTS 23 SEPTEMBER 2019

We would like to bring to your kind notice that, if proposed regulation is finalised as Rule,
the so called E-Pharmacy will pose ethical, legal and quality challenges amounting to
endanger life of many citizens and there by irreparable harm to the society.
An important safeguard in health care is patient examination by the physician; licensed
pharmacist reviews the prescription and guide patient on medication. This approach i.e.
right medicine to right patient from right Registered Medical Practitioner (Prescriber) and
right Registered Pharmacist (Dispenser) will break this noble way of treatment of patient
.The e- pharmacy is looking towards this profession as business.
If e-pharmacy is brought in picture, the patient will miss the services of two professionals
i.e. Doctor and Pharmacist who inform patients of proper administration of drugs, dangerous
side effects, and drug interactions.
As per Rule 67-1 (f) The words and expressions used herein and not defined in this PART
but defined in the Drugs and Cosmetics Act, 1940 and rules made there under shall have
the same meaning assigned to them in that Act or rules, respectively. As per condition of
registration inform 21 AA -The registration holder shall comply with the provisions of the
Drugs and Cosmetics Act, 1940 and the Rules made there under amended from time to
time. This means all the provisions of present Act and Rules are applicable to E-Pharmacy
registration holder.
In draft, however, there is lacks clarity on various issues and proposed provisions are violating
various provisions of present Drugs and Cosmetics Act and Rule such as Section 18(C),
Rule 65(2), 65(9), 65(11) as well as provisions under pharmacy act.
The E-Pharmacy is an off-shoot of modern technology. The benefits of internet pharmacies
propagated are convenience; allow the door delivery of drugs at low cost, but on perusing
following submission, it will be seen that it is not true. The picture presented is misleading
and hiding the facts. The proposed regulation will endanger life of citizens and will
have alarming hazard to society as elaborated follows.
1. Dangers of self-diagnosis and self-medication.
Self-diagnosis and self-medication will lead to health hazard to society. e.g. High
Temperature to human body is due to various diseases, but patients will order drug like
paracetamol via E-Pharmacy. Disease will cross, hazard or fatal level and cannot be
controlled after some stage. Therefore timely opinion of physician and intervention of
pharmacist is imperative and inevitable. This is missing in E-Pharmacy concept as
OTC drugs don’t require prescription of doctor. Even indiscriminate use of OTC drugs
has many side effects. E.g. paracetamol causes a severe liver dysfunction if consumed
indiscriminately. If present formatted E-Pharmacy is brought in picture, consumers can
purchase OTC drugs without ever speaking to a pharmacist or physician, uncontrolled
indiscriminate self-medication will be visible in coming years.

TAMILNADU CHEMISTS 24 SEPTEMBER 2019

2. Misuse of Prescription Drugs.
Government is proposing following provisions in regulation, 67-1. Definitions. - In
this part unless the context otherwise requires,-
(a) “e-pharmacy” means business of distribution or sale, stock, exhibit or offer for
sale of drugs through web portal or any other electronic mode;
(b) “e-pharmacy portal” means a web or electronic portal or any other electronic mode
established and maintained by the e-pharmacy registration holder to conduct
business of e-pharmacy;
(d) “Prescription” means an instruction from a Registered Medical Practitioner to a
patient, written by hand or in any electronic mode duly signed, to dispense a drug
and quantity of drug to a patient;
(e) “Sale by way of e-pharmacy” means a sale whether to a hospital, or dispensary, or
a medical, educational or research institute or to any other person through e-
pharmacy by way of retail sale;”
67P. Procedure for distribution or sale, of drugs through e-Pharmacy,
(1) On receipt of prescription, through e-pharmacy portal, the registered pharmacist
on behalf of the epharmacy registration holder shall verify the details of the patient,
Registered Medical Practitioner and arrange for the dispense of the drugs as per
the instructions of the Registered Medical Practitioner, if not already found
dispensed;
(2) The e-pharmacy registration holder who has received prescription in sub-rule (1)
shall dispense and made arrangements for supply of drugs from any retailer or
wholesaler licensed premises under the Drugs and Cosmetics Act, 1940 and rules
made there under;
(3) The details of the drugs dispensed including the patient details shall be maintained
on the epharmacy portal.
(4) In case of e-prescription, the prescription shall be uploaded on the e-pharmacy
portal and shall be kept in record by the dispenser
On perusing proposed provisions in proposed Rule it is seen that said proposed rules
contradict with present law and’ may attract misuse of prescriptions as elaborated below,
I. It is seen that vide this regulation Govt. is intended to permit distribution or sale of
even prescription drugs on e -pharmacy, this is very serious.
II. In case of prescription drugs, dangers are especially significant; drugs will be dispensed
without a valid prescription. Repeated purchase with same prescription. Prescription
of one patient may be used for other for similar sign and symptoms; alarming thing is
that in spite of every possibility of different diseases. At the same time, there is a risk

TAMILNADU CHEMISTS 25 SEPTEMBER 2019

 of the same prescription will be used multiple times for procuring drugs across different
e-pharmacies. This is an alarm red flag.
III. Indiscriminate use of drugs like antibiotics will lead to drugs resistance like MDR
tuberculosis case.
IV. Another area of concern involves the prescribing-physician’s credentials. The cyber
doctor’s qualifications and his experience.
V. Illegal Purchase of schedule drugs, Habit forming drugs, potent drugs like abortion
(MTP) kit is alarming issue observed severely in past also.
VI. Forgery of prescription/bogus prescription is easily possible in present methodology
amounting to cyber - crime.
VII. The Sale or distribution of an adulterated or misbranded, counterfeit and spurious
drugs control on it will be beyond imagination. There is no strong mechanism available
to check the medicines.
VIII. Ethical issues - In an anarchic world over the Internet, nobody can be sure of what
happens to this information. Large information losses once a security breach has
occurred. Cyber -pharmacies not keeping privacy and confidentiality promises have
also been reported.
IX. It is pertinent to note that in many countries Purchase of prescription drug on e-
pharmacy is strictly prohibited.
X. As per proposed regulation pharmacist of e-pharmacy is supposed to verify the details
of the patient, Registered Medical Practitioner and arrange for the dispense of the
drugs as per the instructions of the Registered Medical Practitioner, if not already
found dispensed. But there is no provision how this will be done. Even consumer and
regulator also will be unable to verify presence of pharmacist.
XI. There is no provision of linkage of doctors and patient with strong unique identity
for specific prescription which will lead to misuse of prescriptions.
XII. As per proposed regulation pharmacist is expected to verify that drugs are not
dispensed on said prescription, this is just impossible as prescription will be scan
copy.
3. Inadequate Regulatory machinery and supervision:
Looking into nature and quantum of e-transaction there will be lack of proper regulatory
checks and balances for exercising regulatory controls on e-pharmacy. Drug sale is
regulated by state licensing authorities, which is feasible for brick and mortar stores.
Present brick and mortar medical stores are approachable to the consumers who reside
within the vicinity of the location of the stores However; such a model of regulation
may not be feasible for E-pharmacies in as much as an online market place is accessible
from any location or state, without there being any checks or control on cross border
sales etc.
TAMILNADU CHEMISTS 26 SEPTEMBER 2019
 Also for consumer there will be jurisdiction issues which lead to difficulty in assess
for justice if required by common people.
4. Storage and transportation:
Absence of a framework or guidelines ensuring the protection of the drugs and medicines
at the time of storage and transportation. There is a possibility of pilferage, loss of
potency and degradation of drugs and medicines during transportation to the consumer’s
house/place. Especially if they are being transported over long distances or are of certain
specification that requires safe handling, cold storage etc.
5. Violation of provision of Pharmacy Act and Regulations 2015.
There will be violation of pharmacy Act provisions as absence of any physical interface
between the consumer and a pharmacist; concerns arise as to the compliance with the
obligation of the provisions of Pharmacy Act and the regulations made there under on
part of the E-pharmacies. Section 42 of the Pharmacy Act provides that no person other
than a registered pharmacist shall compound, prepare, mix, or dispense any medicine
on the prescription of a medical practitioner. At the same time, the Pharmacy Council
of India has framed the Pharmacy Practice Regulations, 2015 which inter alia, prescribe
the obligations and duties of the pharmacists in connection with the preparation and
dispensation of drugs, maintenance of records, patient care, patient secrecy and patient
counseling. As per the provisions under section 2 of Drugs and Cosmetics Act i.e.
application of either laws not barred .- The provisions of this Act shall be in addition to
and not in derogation of, the Dangerous Drugs Act, 1930 (2 of 1930), and any other law
for the time being in force, is self-explanatory. Proposed law is grossly violating this
provision. Therefore liable to set aside.
6. Violation of various provision of D&C Act and rules itself by proposed regulation.
I. There will be two definition ‘prescription’ under same regulation, under present
Rule 65(10) and proposed 67-L (d). As per above mentioned provisions present
definition is also applicable to epharmacy. This is nothing but non application of
mind and arbitrary regulation.
II. As per proposed regulation wholesalers are also permitted to sale/deliver the
drugs to the patient, as per present regulation (Rule 2(g)) Wholesalers cannot
sale drugs to consumer this proposed provision in draft is in contradictory
with the present regulation. The presence of registered pharmacist is also in
question (7).
III. As per Rule 65(1) Any drug shall, if compounded or made in the licensee’s
premises be compounded or made by or under the direct and personal supervision
of a registered Pharmacist.

TAMILNADU CHEMISTS 27 SEPTEMBER 2019

 IV. As per Rule 65 (2) the supply, otherwise than by way of wholesale dealing, of
any drug supplied on the prescription of a Registered Medical Practitioner shall
be affected only by or under the personal supervision of a registered Pharmacist.
E pharmacy will violate these clauses as E-pharmacy pharmacist will not be able
to supervise drug dispensing.
V. As per E- pharmacy regulation online prescription (scan copy) will be forwarded
to brick and mortar medical/pharmacy and they are supposed to dispense the
same. This is violation of Rule 65(2) and 65(11) (C), as per these provisions
original prescription is required to be dispensed and marked as ‘dispensed’. E-
Pharmacy transaction will violate this provision . If it is permitted then such
other prescriptions coming to such licensee will be dispensed by such medical
amounting permission to violate present provision. This will create havoc in
medical field.
VI. Rule 65 (3) (g) provides that sale bill must be signed by the Registered Pharmacist.
Rule 65 (9) provides that drugs specified in Schedule H, H-1 and X shall be sold
on prescription of the Registered Medical Practitioner. Proposed regulation violates
these provisions.
VII. There may be two bills one by actual seller and one bye-pharmacy for the same
transaction, which is valid and legal bill?
VIII.The term prescription is defined under Rule 65(10) of the Drugs and Cosmetics
Rules, 1945. Plain reading of the said definition clearly shows that it does not
recognize prescription in electronic form or scanned copy or photocopy or
prescription forwarded through mobileapps. The practices followed by the illegally
run online pharmacies are clearly in violation of the existing provision of the
D&C Act & Rules.
IX. Auditing of portal is impossible as data is in hand and custody of e-pharmacy
holder. There is not at all provision of audit trail and 21 CFR part 11 compliance
to avoid tampering of data.
X. There is no provision of linkage of data to Govt. portal contemporaneously,
attributed to patient, doctor and prescription so that data cannot be manipulated
by the e-pharmacy.
7. Doctor’s identity cannot be traced also there is no provision for authentic digital sign
and control of regulation like 21 CFR part 11 in order to avoid bogus prescription.
Registration details of all doctors (RMP) is not online therefore it is difficult to link
prescription of particular RMP on this ground as well as there is no digital signature
standardization I validation this will lead to fake prescription and will be one loose end
or syphoning counterfeit and spurious drugs.

TAMILNADU CHEMISTS 28 SEPTEMBER 2019

8. The main object of the Act is required to be kept in mind. The Act of 1940 is brought
into force with clear Intention to prevent entry of sub standards Drugs for maintaining
High standards of medical treatment. That would certainly be defeated if the necessary
concomitant or the medical or surgical treatments were to enter uncontrolled into the
system and the purpose of the act will get diluted. The very evil which the Act intends
to eradicate would continue to exist. That is what is held by Supreme Court in the
judgment report in AIR 1963 SC 665. So also, in another judgment of Division Bench
of Bombay High Court between State of Maharashtra v/s Laxmichand Varchomal
Chugani reported in 1988 (1) FAC 1984. It is held that the basic object and the essence
of the provisions of the Act is that no sub-standard drugs should be sold in market and
no one should sell even a genuine drug without license.
9. In the present setup the license is issued for manufacturing, stock for sale, exhibit for
sale, sell or distribute from a particular premises only. The sale, stock, manufacture or
distribution from outside the licensed premises amounts to an offence, and will be
treated as sale in contravention of Act of 1940. In the proposed setup, when the retailers
sell the goods, the agreement to sell and the delivery is effected Simultaneously, and it
is affected in the licensed premises, while following the provisions of the Act and
Rules. While allowing medicines to be sold bye-pharmacy or online, there will be
absolutely no control of the Drug control Department and there will be chances of
fabricating the prescriptions to cover the fake sales and thereby entire objective of
formation of the Act 1940 and Rules there under will be defeated, hence cannot be
allowed.
10. E-pharmacy business will create lots of questions, one of these, is conditions to be
satisfied regarding stock & sales. Suppose a drug leaves a licensed premises and is in
transit of delivery, whether that will be treated as stock with the licensee and how the
same will be verified, what will be the actual delivery to consumer and what will happen
on the date of delivery, if the drug got expired.
11. Do’s and Don’ts for consumers using online pharmacies are not listed and popularized.
Digital data protection of patient information? There is no precaution mentioned.
12. We must examine the purpose and the aim of the formation of the act. Sale of medicines
online involves risk for the patients rather than the convenience it will provide. In
context to present D&C act & rules and information technology act. It seems that the
online transaction in scheduled drugs is totally violating the act and rules. It is also
particularly to note that; this will lead to a danger to a health of common man.
13. While we think or propose online transactions in the field of drugs, we must observe the
international scenario along with the reason for not allowing the online/internet
transaction in countries like China, Japan, Italy, Ireland, Korea, Spain, Thailand, Turkey,
and Russia Federal where online pharmacy is not permitted.
TAMILNADU CHEMISTS 29 SEPTEMBER 2019
14. We should also learn from the bad experiences and difficulties observed by the countries
which allowed the online/internet pharmacy in country. In recent past many cases of
illegal sale of abortion kit was unearth. We have recently observed that in Mumbai IT
student consumed 200 plus sleeping pill for suicide. E pharmacy will open Pandora
box for such unfortunate incidents. Youth of the country may be on stake.
15. Accountability: The accountability of e-pharmacy is not spelled out in regulation if
anything goes wrong, such as of a wrong medicine is dispensed or substandard medicine
is dispensed.
16. Statutory Compliance Clarity: It is not clear whether an e-pharmacy owner can operate
an e-pharmacy if the owner also owns a brick-n-mortar pharmacy within the same state
or can show a license of any pharmacy in any state where they intend to sell the drugs.
17. Delivery by courier is not prohibited? Dispensing of final handing of the medicines
must be done by pharmacist only. How can this be ascertained in case of an internet
pharmacy? Do they do only packaging of dispensed medicines? How presence of
pharmacist at e-pharmacy portal assured .
18. The controversies gained media attention after the anthrax cases in 2001 which saw
people ordering ciprofloxacin without a prescription. Use of “cyber doctors,” the
dispensing of drugs without prescriptions, and the import of prescription medications
are just the tip of the iceberg.
19. “Cyber doctors” evaluate patients through questionnaires and checklists and prescribe
medication based on this communication . These online consultations forgo the detailed
patient evaluation and physical evaluation that is considered necessary before providing
treatment. Recently Mumbai high court permitted filing of FIR against such doctor.
20. In addition, illegal websites may disappear without trace, at as lightest hint of a regulatory
action.
21. The US Food and Drug Administration (FDA) with INTERPOL and 200 law
enforcement agencies around the world conducted a global action against online
pharmacies, in the year 2014, wherein 237 people were arrested and more than 10,600
illicit websites were shut down. The pharmaceutical crime program supported by major
pharmaceutical companies in 2013 helped crackdown on illicit sites.
22. In India too, the Maharashtra FDA have approached the Drugs Controller General of
India to curb the illegal online sale of medicines.
23. Role of Consumers awareness is the key to curb such fraudulent practices; consumers
need to be educated about the need to verify the authenticity of the service provider as
well as the product and to avoid sites that sell drugs without a legal prescription .

TAMILNADU CHEMISTS 30 SEPTEMBER 2019

24. Registration details of all doctors (RMP) is not online therefore it is difficult to link
prescription of particular RMP on this ground as well as there is no digital signature
standardization / validation hence, this will lead to fake prescription and will be one
loose end or syphoning counterfeit and spurious drug.
25. Though proposed draft prohibit sale of drug falling under NDPS Act and Rule but it is
observation that such drugs are purchased illegally through e-pharmacy. FDA
Maharashtra unearthed cases in recent past, sleeping pills and abortion kit misuse.
Hazard of habit forming drugs and addiction of young population is big threat.
26. It seems that Govt. is under pressure of Rich and corporate lobby to make such Rules
which will finish the well-established noble profession , i.e. right medicine to right
patient from right Registered Medical Practitioner (Prescriber) and right Registered
Pharmacist (Dispenser) and will take away noble way of treatment of patient.
27. There is lack of administrative strength again Government own study report support
that we are lacking lots in regulatory setups.
28. It will attract major impact on small timers and shops based at villages and small towns.
29. It will also give economical set back to 8 lac chemists and 40 lac workers and their
families .
30. It will also impact on dream of our Prime Minister - Shri. Narendraji Modi that “Sabke
Saath Sabka Vikas”
31. Though proposed Regulation speak about data to be stored in India but how access of
the data from outside India can be prevented. What is check and control points for the
same?
32. As per proposed Regulation, e-pharmacy registration holder shall have a facility for
customer support and grievance redressal of all stakeholders but this facility is through
customer help line supported by registered pharmacist. There is no guarantee or assurance
that person online will be a pharmacist.
33. In provision, Rule 67(5) there is Prohibition of advertisement of drugs through e-
pharmacy. However in the provision of proposed Rule 67(V) it is proposed that the e-
pharmacy registration holder shall maintain and update, from time to time, the
information regarding the drugs availability, types of drugs offered for sale, supply
channels or vendors lists, details of registered pharmacist, registered medical practitioner
(If any) and any other requirements of the Drugs and Cosmetic Act and Rule there
under on e-pharmacy portal. There is contradiction in these provisions itself.
34. There is no mention of whether e-pharmacy registration holder will require brick and
mortar license under Rule 64 and there is no provision for premises requirement if, it is
not required then same is violation of Section 18C as license is required for offer for
sale.

TAMILNADU CHEMISTS 31 SEPTEMBER 2019

35. As per proposed Regulation licensing Authority is Central Government this is against
de-centralization of authority as per policy of Central Government. There will be dual
control of Central and State Government. It is well known fact that dual control always
fails . Why State is not licensing Authority is unfold paranoma.
36. Success of the proposed e-pharmacy model is impossible in shaky and cloudy regulatory.
US-FDA has recently sent warning letters to companies illegally selling drugs. US-
FDA is in process of removing violated websites.
37. In view of this proposed regulation which also violates present many laws like ...
a) Supply of medicines not made as per quantity in prescriptions and denial of cut /
loose strips and quantity.
b) Huge discounts beyond the available margins are giving out of pocket by burning
own capital will attract irrational competition. It may create risk for entry of spurious
medicines in the market.
c) Advertisements to attract the peoples which are today also illegally shown; many
of them are violating the present act and rules.
d) Lack of man power to inspect the e-pharmacies.
e) It is very suspicious act i.e. in public notice and proposed notification draft that;
License / Registration - why it is not kept state-wise as it prevails in public notice
38. Keeping in mind all the above reasons and the legal positions, we strongly oppose the
move of entry to online sale of medicines via E-Portal in this Nobel profession. Which
is nothing but business module. It is also very important to note that, Drug is life saving
and not general merchandise commodity.
We also reserve our right to comment, suggest, and object and to go far an available remedy
to protect our interest and also the larger public interest and request you to please allow us
to present our views in person.
Thanking you
Yours faithfully,
For AIOCD

(J.S. Shinde) (Rajiv Singhal)

President Hon Gen Secretary

TAMILNADU CHEMISTS 32 SEPTEMBER 2019

ESTD.] [1975

AIOCD
ALL INDIA ORGANISATION OF CHEMISTS & DRUGGISTS ®
201, Safalya Bldg., 2nd Floor, Opp. Jaigopal Industrial Estate, Baburao Parulekar Marg, Dadar (W), Mumbai 400 028.
Tel.: 2430 6889 / 2430 6874 / 6145 2929 l Fax: 2430 6973 / 6145 2925 l Visit us on : www.aiocd.net
President : Hon. Gen. Secretary :
J.S. SHINDE RAJIV SINGHAL
Email: aiocd@vsnl.net M/s. Shree Radhey Trade Logistics,
jagannath.shinde@aiocd.com Prabhu Kripa 120, S.R. Compound,
Lasudia, Indore - 452 010, M.P.
September 02, 2019 Tel. : 0731 - 4002350 Mob.: 9425056394
E-mail: gsrajiv.singhal@aiocd.com
Ref: APH/AIOCD/451/2019

ALL THE DISTRIBUTION / MARKETING / FINANCE HEAD OF THE PHARMA COMPANIES

Dear All,
Kindly refer to our various communications regarding smooth functioning of business.
We have been given so many complain regarding the supply of goods directly/indirectly to On
Line Pharmacies on heavy additional discounts the result they are offering 30-40% discount directly
to the public.
It is creating bad impact on our image in public. We have highlighted this issue so many times but
sorry to say that still it is not stopped by some of the companies.
You are therefore advised to offer our Chemists the same schemes whatever is given to them or
to issue clear cut guide line for the same, so that 8.5 lac. Chemists of the country can survive in
the market.
Hope that the necessary instructions will be issued immediately.
Thanking you
Yours faithfully,
For AIOCD

(J.S. Shinde) (Rajiv Singhal)

President Hon Gen Secretary
CC : All State Office Bearers.
Regd. Office : AIOCD, C/o. B.C.D.A., 10, Bonfield Lane, 1st Floor, Kolkata - 700 001.

TAMILNADU CHEMISTS 33 SEPTEMBER 2019

 tUªJ»nwh«
jÄœehL kUªJ tÂf®fŸ r§f¤âš mik¥ò brayhsU«, ehk¡fš kht£l
kUªJ tÂf®fŸ r§f¤â‹ brayhsUkhd âU. N.R.P. m‹gHf‹ mt®fË‹
jªijah® âU. M.gHÅrhÄ mt®fŸ 08.09.2019 m‹W ïa‰if vŒâdh®. m‹dhÇ‹
FL«g¤jhU¡F jÄœehL kUªJ tÂf®fŸ r§f¤â‹ rh®ãš Mœªj ïu§fiy
bjÇɤJ¡ bfhŸ»nwh«.
ÉG¥òu« kht£l« É¡»uth©o Ãô jÄœehL bko¡fš cÇikahs® ÃahÞ mfkJ
mt®fË‹ jhah® 18.07.2019 m‹W ïa‰if vŒâdh®.
òJ¡nfh£il kht£l«, fªj®t¡nfh£il, $ Ûdh£á bko¡fšÞ cÇikahsU«,
K‹dhŸ kht£l¤ jiytUkhd âU. P. f©z‹ mt®fŸ 23.06.19 m‹W ïa‰if vŒâdh®.
òJ¡nfh£il kht£l«, m©l¡Fs«, $ RÓyh bko¡fšÞ, cÇikahsÇ‹ jªijí«,
kht£l¤â‹ _¤j cW¥ãduhfî« És§»a âU. M. uhk_®¤â ãŸis mt®fŸ 31.08.2019
m‹W ïa‰if vŒâdh®.
ntÿ® kht£l« miz¡f£L jhY¡fh njt‹ bko¡fÞ âU. D. njtehj‹ mt®fŸ
jf¥gdh® Dr. V.P. jdghš RIMP mt®fŸ 23.07.2019 m‹W ïa‰if vŒâdh®.
ÉUJef® kht£l« uh#ghisa« jhYfh fÉjh bko¡fšÞ cÇikahs® âU. A.
khÇK¤J mt®fË‹ jhah® âUkâ. A. Ójhy£RÄ mt®fŸ 29.07.2019 m‹W ïa‰if vŒâdh®.
j§fŸ FL«g m§f¤âdiu ïHªJ JaU‰WŸs midtuJ FL«g¤jhU¡F« khÃy
r§f¤â‹ rh®ghf ïu§fiy bjÇɤJ¡bfh©L mt®fsJ M‹kh rhªâaila všyh« tšy
ïiwtid ãuh®¤â¡»‹nwh«.

cW¥ãd® FL«g ey Ãâ

âUtŸq® kht£l«, âUnt‰fhL gFâ, thr‹bko¡fš cÇikahs® âU. thR mt®fŸ ïa‰if
vŒâaij K‹Å£L FL«g ey Ãâ %. 25,000/-¡fhd fhnrhiyia âU. thR mt®fË‹ kidÉ
âUkâ. gɤuh mt®fËl« âUtŸq® kht£l jiyt® âU. S.B. uhft‹ mt®fŸ k‰W« kht£l
îth»fshš tH§f¥g£lJ.
TAMILNADU CHEMISTS 34 SEPTEMBER 2019